Gleaning critical technical knowledge and building important international relationships is top of the agenda for rising Australian biotechnology star, DendriMed Research Director Dr Raisa Monteiro, when she meets with leading industry figures in the US in May.
One of two Australian life scientists chosen from a highly competitive field of candidates for the prestigious 2008 Advancing BioBusiness Award, Russian-born Dr Monteiro will attend the worlds largest biotechnology meeting, the Biotechnology Industry Organisation (BIO) convention, which attracts over 22,000 delegates from around the globe.
A tailored program of meetings will also be scheduled for her with leading American players including venture capital firms, research institutes, biotechnology entrepreneurs and biopharmaceutical companies, to help build valuable international networks, knowledge and collaborations.
The Advancing BioBusiness Award is an innovative scheme by Merck Sharp & Dohme and Advance, a dynamic, diverse global community of Australian professionals overseas committed to advancing Australia and Australians.
Russian-born Dr Monteiro, whose late father worked with the team that successfully cloned Dolly the sheep, is one of Australias brightest hopes in biotechnology, having moved here in 2002 with her Australian husband, an academic at the University of Queensland. During her 10-year career as a polymer scientist in America and Australia, she has notched up seven US patents with another three applications pending for technology she conceived and developed.
Now at DendriMed, her focus has turned to using smart polymer-based nanostructures to deliver drugs to targeted tissue and organs.
Dr Monteiro said through the Advancing BioBusiness Award, she wants to overcome the tyranny of distance and open up business opportunities in the global marketplace by meeting face-to-face with US biopharmaceutical heavyweights.
|Contact: Jackie Crossman|